Rapamycin attenuates acute lung injury induced by LPS through inhibition of Th17 cell proliferation in mice

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Yan, Zhao ^a   Xiaoyu, Zhang ^a   Zhixin, Song ^a   Di, Qi ^a   Xinyu, Deng ^a   Jing, Xia ^a   Jing, He ^a   Wang, Deng ^a   Xi, Zhong ^a   Chunrong, Zhang ^a   Daoxin, Wang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; GFI1 PROTEIN, MOUSE; INTERLEUKIN 17; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; LIPOPOLYSACCHARIDE; RAPAMYCIN; RETINOID RELATED ORPHAN RECEPTOR GAMMA; SOCS3 PROTEIN, MOUSE; STAT3 PROTEIN; STAT3 PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR;

ACUTE LUNG INJURY; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MALE; MOUSE; TH17 CELL;

ACUTE LUNG INJURY; ANIMALS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; INTERLEUKIN-17; INTERLEUKINS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; SIROLIMUS; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING 3 PROTEIN; TH17 CELLS; TRANSCRIPTION FACTORS;

EID: 84959019611     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20156     Document Type: Article

References (49)

1. Ferguson, N. D. et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive care medicine 38, 1573-1582 (2012).
2. Weiland, J. E. et al. Lung Neutrophils in the Adult Respiratory Distress Syndrome: Clinical and Pathophysiologic Significance 1, 2. American Review of Respiratory Disease 133, 218-225 (1986).
3. Summers, C. et al. Neutrophil kinetics in health and disease. Trends Immunol 31, 318-324 (2010).
4. Kim, M. et al. Staphylococcus aureus-derived extracellular vesicles induce neutrophilic pulmonary inflammation via both Th1 and Th17 cell responses. Allergy 67, 1271-1281 (2012).
5. Iwakura, Y., Ishigame, H., Saijo, S., Nakae, S. Functional specialization of interleukin-17 family members. Immunity 34, 149-162 (2011).
6. Risso, K. et al. Early infectious acute respiratory distress syndrome is characterized by activation and proliferation of alveolar T-cells. European Journal of Clinical Microbiology & Infectious Diseases 34, 1111-1118 (2015).
7. Ye, P. et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. The Journal of experimental medicine 194, 519-528 (2001).
8. Aujla, S. J. et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nature medicine 14, 275-281 (2008).
9. Hu, W.-C. Acute Respiratory Distress Syndrome is a TH17-like and Treg immune disease. arXiv preprint arXiv:1311.4384 (2013).
10. Harris, T. J. et al. Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. The Journal of Immunology 179, 4313-4317 (2007).
11. Zhao, Y. et al. The potent, selective ROR? t blocker, VTP-43742, suppresses Th17 production in vivo and provides greater benefit than IL-17 blockade in the EAE model of autoimmunity (THER3P. 968). The Journal of Immunology 194, 68.61-68.61 (2015).
12. Kurebayashi, Y. et al. PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORgamma. Cell Rep 1, 360-373 (2012).
13. Ma, J. et al. Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. The Journal of clinical investigation 120, 103 (2010).
14. Yoshida, T. et al. Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema. Nat Med 16, 767-773 (2010).
15. Nadon, A. M. et al. Rtp801 suppression of epithelial mTORC1 augments endotoxin-induced lung inflammation. Am J Pathol 184, 2382-2389 (2014).
16. Fielhaber, J. A. et al. Inhibition of mammalian target of rapamycin augments lipopolysaccharide-induced lung injury and apoptosis. J Immunol 188, 4535-4542 (2012).
17. Yen, Y. T. et al. Enhancing autophagy with activated protein C and rapamycin protects against sepsis-induced acute lung injury. Surgery 153, 689-698 (2013).
18. Lorne, E. et al. Participation of mammalian target of rapamycin complex 1 in Toll-like receptor 2-and 4-induced neutrophil activation and acute lung injury. Am J Respir Cell Mol Biol 41, 237-245 (2009).
19. Chen, D., Ma, T., Liu, X. W., Yang, C., Liu, Z. Rapamycin reverses paraquat-induced acute lung injury in a rat model through inhibition of NFkappaB activation. Int J Clin Exp Pathol 8, 4627-4638 (2015).
20. Shin, H.-J. et al. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+ CD25+ Foxp3+ regulatory T cells. Blood 118, 2342-2350 (2011).
21. Battaglia, M. et al. Rapamycin promotes expansion of functional CD4+ CD25+ FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. The Journal of Immunology 177, 8338-8347 (2006).
22. Kopf, H., Gonzalo, M., Howard, O. Z., Chen, X. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. International immunopharmacology 7, 1819-1824 (2007).
23. Ichiyama, K. et al. Gfi1 negatively regulates T(h)17 differentiation by inhibiting RORgammat activity. Int Immunol 21, 881-889 (2009).
24. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155, 1151-1164 (1995).
25. Taylor, A., Verhagen, J., Blaser, K., Akdis, M., Akdis, C. A. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology 117, 433-442 (2006).
26. Nakajima, T. et al. T cell pathways involving CTLA4 contribute to a model of acute lung injury. J Immunol 184, 5835-5841 (2010).
27. Adamzik, M. et al. An increased alveolar CD4+ CD25+ Foxp3+ T-regulatory cell ratio in acute respiratory distress syndrome is associated with increased 30-day mortality. Intensive Care Med 39, 1743-1751 (2013).
28. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., Stockinger, B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189 (2006).
29. Ziegler, S. F., Buckner, J. H. FOXP3 and the regulation of Treg/Th17 differentiation. Microbes Infect 11, 594-598 (2009).
30. Kimura, A., Kishimoto, T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol 40, 1830-1835 (2010).
31. De Simone, V. et al. Th17-type cytokines, IL-6 and TNF-alpha synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene 34, 3493-3503 (2015).
32. Liu, Y. et al. IL-17A and TNF-Exert Synergistic Effects on Expression of CXCL5 by Alveolar Type II Cells In Vivo and In Vitro. The Journal of Immunology 186, 3197-3205 (2011).
33. Jones, C. E., Chan, K. Interleukin-17 Stimulates the expression of interleukin-8, growth-related oncogene-? , and granulocyte-colony-stimulating factor by human airway epithelial Cells. American Journal of Respiratory Cell and Molecular Biology 26, 748-753 (2002).
34. Boari, J. T. et al. IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils. PLoS pathogens 8, e1002658 (2012).
35. Liu, Y. et al. IL-17A and TNF-? exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro. The Journal of Immunology 186, 3197-3205 (2011).
36. D'Souza, N. B., Mandujano, F. J., Nelson, S., Summer, W. R., Shellito, J. E. CD4+ T lymphocyte depletion attenuates lipopolysaccharide-induced tumor necrosis factor secretion by alveolar macrophages in the mouse. Lymphokine and cytokine research 13, 359-366 (1994).
37. Ma, C. S. et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. The Journal of experimental medicine 205, 1551-1557 (2008).
38. Renner, E. D. et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T H 17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. Journal of Allergy and Clinical Immunology 122, 181-187 (2008).
39. Dang, E. V. et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146, 772-784 (2011).
40. Yang, E. J. et al. EGCG attenuates autoimmune arthritis by inhibition of STAT3 and HIF-1alpha with Th17/Treg control. PLoS One 9, e86062 (2014).
41. Shi, L. Z. et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208, 1367-1376 (2011).
42. Ikejiri, A. et al. Dynamic regulation of Th17 differentiation by oxygen concentrations. Int Immunol 24, 137-146 (2012).
43. Delgoffe, G. M. et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol 12, 295-303 (2011).
44. He, J. et al. Insulin upregulates the expression of epithelial sodium channel in vitro and in a mouse model of acute lung injury: role of mTORC2/SGK1 pathway. Exp Cell Res 331, 164-175 (2015).
45. Qi, D. et al. 17beta-estradiol suppresses lipopolysaccharide-induced acute lung injury through PI3K/Akt/SGK1 mediated upregulation of epithelial sodium channel (ENaC) in vivo and in vitro. Respir Res 15, 159 (2014).
46. Aujla, S. J. et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14, 275-281 (2008).
47. Tang, L. et al. Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome. Mediators of inflammation 2014 (2014).
48. Koya, T. et al. Differential effects of dendritic cell transfer on airway hyperresponsiveness and inflammation. Am J Respir Cell Mol Biol 41, 271-280 (2009).
49. Zhao, Y. et al. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates airway inflammation by inhibiting the proliferation of effector T cells in a murine model of neutrophilic asthma. Immunol Lett 157, 9-15 (2014).